comparemela.com

Latest Breaking News On - Chronic lung allograft dysfunction - Page 1 : comparemela.com

Zambon to Attend the CHEST Annual Meeting 2022

/PRNewswire/ Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people s health and the quality of patients .

United statesMariem budevLindsay roccoPaola castellaniBonnie ortegaPrnewswire zambonDeborahj levinePulmonary councilZambon united states ltdHeart transplantation programMusic city centerDrug administrationAmerican college of chest physiciansScientific program committeeCorporate communicationsElixir health public relations

Zambon to present data on lung transplantation trends and survival rates in Europe at ISHLT 2022

/PRNewswire/ Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people s health and the quality of patients .

United statesLindsay roccoAnn bartling sam purewalPaola castellaniBonnie ortegaCabiria reinaPrnewswire zambonZambon united states ltdDevelopment programCorporate communicationsElixir health public relationsInternational society for heartBronchiolitis obliterans syndromeChronic lung allograft dysfunctionInternational societyLung transplantation

ALTAVANT SCIENCES TO PRESENT DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesSumitomo dainippon pharmaSumitovant biopharmaPrnewswire altavant sciencesInternational society for heart lung transplantationAltavant sciencesInsights for drug developmentSumitovant biopharma ltdJohnb hynes memorial convention centerReceptor blockage supporting developmentInternational societyLung transplantationChronic lung allograft dysfunctionProvide essential insightsMemorial convention centerDemonstrates distribution

ALTAVANT SCIENCES TO PRESENT DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530

/PRNewswire/ Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,.

United statesSumitomo dainippon pharmaSumitovant biopharmaPrnewswire altavant sciencesInternational society for heart lung transplantationAltavant sciencesInsights for drug developmentSumitovant biopharma ltdJohnb hynes memorial convention centerReceptor blockage supporting developmentInternational societyLung transplantationChronic lung allograft dysfunctionProvide essential insightsMemorial convention centerDemonstrates distribution

ALTAVANT SCIENCES TO PRESENT DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530

/PRNewswire/ Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,.

United statesSumitomo dainippon pharmaSumitovant biopharmaPrnewswire altavant sciencesInternational society for heart lung transplantationAltavant sciencesInsights for drug developmentSumitovant biopharma ltdJohnb hynes memorial convention centerReceptor blockage supporting developmentInternational societyLung transplantationChronic lung allograft dysfunctionProvide essential insightsMemorial convention centerDemonstrates distribution

vimarsana © 2020. All Rights Reserved.